Skip to main content
. Author manuscript; available in PMC: 2026 Jun 2.
Published in final edited form as: Sleep Med. 2025 Jun 6;133:106607. doi: 10.1016/j.sleep.2025.106607

Table 3.

Hypersomnolence in neurological disorders.

Neurological Disorder Hypersomnolence Fatigue Remarks References
Parkinson’s disease 20–40 % 30–70 % Apathy in 10 % [84–88]
Alzheimer disease 20–50 % [147]
Stroke 20–40 % 40–60 % Often ENS in thalamic/sub-cortical stroke. [78–80]
Epilepsy 20–30 % [148,149]
Multiple Sclerosis 10–20 % >70 % Rarely symptomatic narcolepsy [89,90,150]
Neuromuscular disorders 20–40 % 40–60 % [151,152]
Autoimmune/paraneoplastic 28 % 61–65 % [153,154]
Migraine/headache 20–40 % [155]
Narcolepsy >95 % >70 % [156,157]
Idiopathic hypersomnia >95 % >70 % [2]
RLS 10–20 % 20–40 % [158]

RLS: restless legs syndrome; ENS: excessive need for sleep.